1. Biondi A, Valsecchi MG, Seriu T et al. (2000) Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group. Leukemia 14(11): 1939–1943
2. Coppes MJ, Tubergen DG, Arceci RJ (eds) (2001) Hematology/oncology clinics of North America. Pediatric oncology in the 21st century, part I. Vol 15, No 4. Saunders, Philadelphia London Toronto
3. Coppes MJ, Tubergen DG, Arceci RJ (eds) (2001) Hematology/oncology clinics of North America. Pediatric oncology in the 21st century, part II. Vol No 5. Saunders, Philadelphia London Toronto
4. Creutzig U, Henze G (eds) (2001) Leitlinien für die Diagnostik und Therapie in der Pädiatrischen Onkologie, 2. Aufl. Zuckschwerdt Verlag, München Bern Wien New York
5. Creutzig U, Berthold F, Boos J et al. (2001a) Verbesserung der Prognose bei Kindern mit AML: Ergebnisse der Studie AML-BFM 93. Klin Pädiatr 213: 175–185